Connection
Scot Sedlacek to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Scot Sedlacek has written about Antimetabolites, Antineoplastic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.108 |
|
|
|
-
O'Shaughnessy J, Koeppen H, Xiao Y, Lackner MR, Paul D, Stokoe C, Pippen J, Krekow L, Holmes FA, Vukelja S, Lindquist D, Sedlacek S, Rivera R, Brooks R, McIntyre K, Brownstein C, Hoersch S, Blum JL, Jones S. Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clin Cancer Res. 2015 Oct 01; 21(19):4305-11.
Score: 0.108